bisabolangelone

from the roots of Angelica koreana; structure in first source

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

1.	Ulcer 06/22/2009 - "Evaluate the anti-ulcer effects of bisabolangelone from Angelica polymorpha Maxim and provide the basic data to further study for the Angelica polymorpha and bisabolangelone. " 06/22/2009 - "The anti-ulcer activities of bisabolangelone from Angelica polymorpha." 06/22/2009 - "Bisabolangelone is the main anti-ulcer active compound of Angelica polymorpha, and remarkably preventive and therapeutic action on gastric ulcer. " 06/22/2009 - "It is possible that bisabolangelone inhibited the activity of the H(+)/K(+)-ATPase, then reducing the secretion of H(+), and the anti-ulcer mechanism of bisabolangelone was deserved to be further studied."
2.	Stomach Ulcer (Gastric Ulcer) 06/22/2009 - "Bisabolangelone is the main anti-ulcer active compound of Angelica polymorpha, and remarkably preventive and therapeutic action on gastric ulcer. "
3.	Neoplasms (Cancer) 09/01/2013 - "Bisabolangelone (BISA), isolated from the roots of Angelica koreana, has many pharmacological activities, such as anti-tumor, anti-microbial, antioxidant, and anti-inflammatory activities. "
4.	Inflammation (Inflammations) 02/01/2010 - "These results indicate that bisabolangelone inhibits LPS-stimulated inflammation through the blocking of NF-kappaB and MAPK pathways in macrophages, and demonstrated that bisabolangelone possesses anti-inflammatory properties."

1.	NF-kappa B (NF-kB)
2.	Antioxidants
3.	Adenosine Triphosphatases (ATPase)